Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q3

2269.TEDINET S100Q6O2
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥798.1bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.01T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥770.0bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥64.7bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥79.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥66.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥94.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥82.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥69.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥84.9bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥47.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥87.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥56.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥49.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥61.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.21Tat 2022-12-31Cons.Assets
Total assets¥1.12Tat 2022-03-31Cons.Assets
Total assets¥1.16Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥466.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥404.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥748.1bnat 2022-12-31Cons.Net assets
Net assets / equity¥713.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥696.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥87.7bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥67.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥85.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥60.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥39.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥36.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥127.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥75.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥41.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥27.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥45.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥21.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥77.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥9.8bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥336.242022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.132022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥607.242021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥387.812021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.32021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio58.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-12-31¥649.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-12-31¥649.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥542m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-12-31¥45.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥21.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥798.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥798.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥557m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥66.2bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.1bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2021-04-01 → 2021-12-31¥626.3bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2021-04-01 → 2021-12-31¥625.8bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥503m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2021-04-01 → 2021-12-31¥61.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2021-04-01 → 2021-12-31¥144.4bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2021-04-01 → 2021-12-31¥144.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2021-04-01 → 2021-12-31¥18.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥770.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥770.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥775m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥80.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 522
ItemContextValueUnit
Operating incomePrior1YTDDuration_ReconcilingItemsMember-1091000000JPY
Operating incomePrior1YTDDuration79010000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E21902-000FoodReportableSegmentsMember649397000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E21902-000PharmaceuticalReportableSegmentsMember148686000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember798083000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration798083000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E21902-000FoodReportableSegmentsMember542000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E21902-000PharmaceuticalReportableSegmentsMember14000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember557000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-557000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E21902-000FoodReportableSegmentsMember649939000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E21902-000PharmaceuticalReportableSegmentsMember148701000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember798640000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-557000000JPY
Net salesCurrentYTDDuration798083000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E21902-000FoodReportableSegmentsMember45125000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E21902-000PharmaceuticalReportableSegmentsMember21037000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember66163000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-1424000000JPY
Operating incomeCurrentYTDDuration64739000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第14期第３四半期（自　2022年10月１日　至　2022年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)明治ホールディングス株式会社
Company name in english cover pageFilingDateInstantMeiji Holdings Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役 社長 CEO　川村　和夫
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区京橋二丁目４番16号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3273)4001(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営管理部長　島田　勇人
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区京橋二丁目４番16号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(3273)4001(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営管理部長　島田　勇人
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE21902
Fund codeFilingDateInstant－
Security codeFilingDateInstant22690
Filer name in japaneseFilingDateInstant
Original text (Japanese)明治ホールディングス株式会社
Filer name in englishFilingDateInstantMeiji Holdings Co.,Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass